Laboratories
nb
Sample type
instrument
Age mean-SD (range) BST Med [5-95 %] F Med [5-95 %] M Med % of M [5-95 %] <1µg/L Nb (%) >8 µg/L Nb (%) >11.4 µg/L Nb (%)
local routine diagnosis
adults
681 (82.5%)
serum
adults
U250
56.0 ± 16.7 (20-94)
4.97 [2.08; 17.4]
(57.8%) 4.79 [2.1; 16.6] (42.2%) 5.47 [2.2; 17.7] NS
6 (0.9%)
147 (21.6%)
76 (11.2%)
children teenagers
143 (17.3%)
serum
children teenagers
U250
10.4 ± 6.2 (0-20)
4.71 [2.14; 18.1]
(42.7%) 4.21 [2.1; 11.5] (57.3%) 5.06 [2.2; 19.1] NS
0
26 (18.2%)
16 (11.2%)
Interlab healthy donors (HD)
7 labs
636
serum
adults
U250
49.3 ± 17.9 (18-95) 4.4 [2.0; 9.0] (56.5%) 4.6 [2.2; 8.8] (43.5%) 4.7 [2.0; 9.1] NS
3 (0.47%)
50 (7.9%)
7(1.1%) [12.5-20.3]
1 lab
54
Plasma
adults
U250
NA
4.0 [1.7; 10.2] NS
NA
NA
0
6 (11.1%)
2 (3.7%) [14.9-20.0]
1 lab
27
serum
adults
U100
55.5 ± 24.4 (18-95) 3.4 [1.9; 7.3] NS (48.1%) 4.0 [2.0; 7.0] (51.9%) 3.4 [18; 10.8] NS
0
1 (3.7%)
1 (3.7%) [17.6]
3 labs
56
serum
teenagers
U100 (6) U250 (50) 15.8 ± 1.62 (10-117.9) 2.6 [1.2-5.3] p<0.001 (46.4%) 2.7 [1.2; 5.3] [53.6%) 2.6 [1.3; 5.1] NS
0
1 (1.8%) [8.3]
0
1 lab
15
serum
children
U100
3.9 ± 2.55 (1-9)
5.0 [3.2; 11.1] p=0.0184 (20%) 5.0 [4.3-7.5] (80%) 5.0 [3.2; -11.5] NS
0
3 (20%)
1(6.7%) [13,0]
1 lab
51
serum
new borns
U250
3days
6.0 [2.5;13.2] p<0.0001 (56.9%) 5.3 [2.6-9.0)] NS (43.1%) 6.1 [4.2; 11.1] p=0.034
0
10 (19.6%)
2 (3.9%)[11.6-13.2]